CFHR5 Chromosome 1
Complement factor H related 5
Upload your DNA to see your personal genotypes for variants in CFHR5.
What This Gene Does
This gene is a member of a small complement factor H (CFH) gene cluster on chromosome 1. Each member of this gene family contains multiple short consensus repeats (SCRs) typical of regulators of complement activation. The protein encoded by this gene has nine SCRs with the first two repeats having heparin binding properties, a region within repeats 5-7 having heparin binding and C reactive protein binding properties, and the C-terminal repeats being similar to a complement component 3 b (C3b) binding domain. This protein co-localizes with C3, binds C3b in a dose-dependent manner, and is recruited to tissues damaged by C-reactive protein. Allelic variations in this gene have been associated, but not causally linked, with two different forms of kidney disease: membranoproliferative glomerulonephritis type II (MPGNII) and hemolytic uraemic syndrome (HUS). [provided by RefSeq, Jan 2010]
Gene Info
Gene Group
"Sushi domain containing|Complement system regulators and receptors"
Locus Type
gene with protein product
Location
1q31.3
Ensembl
ENSG00000134389
Associated Conditions (7)
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II
CFHR5 deficiency
Atypical hemolytic-uremic syndrome
Inborn genetic diseases
C3 glomerulonephritis
Chronic kidney disease
Kidney disorder
Key Variants
RS111327589
Conflicting classifications of pathogenicity
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II
Health Risk
RS138529008
Conflicting classifications of pathogenicity
CFHR5 deficiency, CFHR5 deficiency
Health Risk
RS138834145
Conflicting classifications of pathogenicity
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Atypical hemolytic-uremic syndrome, CFHR5 deficiency
Health Risk
RS141321678
Conflicting classifications of pathogenicity
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Atypical hemolytic-uremic syndrome, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II
Health Risk
RS143240067
Conflicting classifications of pathogenicity
Health Risk
RS143599784
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS144438200
Conflicting classifications of pathogenicity
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II
Health Risk
RS146025130
Conflicting classifications of pathogenicity
Health Risk
RS147488267
Conflicting classifications of pathogenicity
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II
Health Risk
RS149905969
Conflicting classifications of pathogenicity
Inborn genetic diseases, Inborn genetic diseases
Health Risk
RS181511327
Conflicting classifications of pathogenicity
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II
Health Risk
RS200176406
Conflicting classifications of pathogenicity
CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Inborn genetic diseases, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II
Health Risk
All Variants (39)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS111327589 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS138529008 | Health Risk | Conflicting classifications of pathogenicity | CFHR5 deficiency, CFHR5 deficiency |
| RS138834145 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Atypical hemolytic-uremic syndrome, CFHR5 deficiency |
| RS141321678 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Atypical hemolytic-uremic syndrome, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS143240067 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS143599784 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS144438200 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS146025130 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS147488267 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS149905969 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS181511327 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS200176406 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Inborn genetic diseases, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS201073457 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFHR5 deficiency, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS201084185 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFHR5 deficiency, Inborn genetic diseases |
| RS201714199 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS202093724 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS35957013 | Health Risk | Conflicting classifications of pathogenicity | C3 glomerulonephritis, C3 glomerulonephritis |
| RS368209619 | Health Risk | Conflicting classifications of pathogenicity | CFHR5 deficiency, CFHR5 deficiency |
| RS370641856 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFHR5 deficiency, Inborn genetic diseases |
| RS371283133 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFHR5 deficiency, C3 glomerulonephritis |
| RS373158868 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, C3 glomerulonephritis, Inborn genetic diseases |
| RS373318468 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS375843181 | Health Risk | Conflicting classifications of pathogenicity | C3 glomerulonephritis, CFHR5 deficiency, Inborn genetic diseases |
| RS377160543 | Health Risk | Conflicting classifications of pathogenicity | Atypical hemolytic-uremic syndrome, Inborn genetic diseases, C3 glomerulonephritis |
| RS41299613 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, Chronic kidney disease, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS534950713 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, CFHR5 deficiency, C3 glomerulonephritis |
| RS544857720 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS550747814 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFHR5 deficiency, C3 glomerulonephritis |
| RS565457964 | Health Risk | Conflicting classifications of pathogenicity | CFHR5 deficiency, Kidney disorder, CFHR5 deficiency |
| RS74323799 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS751010317 | Health Risk | Conflicting classifications of pathogenicity | CFHR5 deficiency, C3 glomerulonephritis, CFHR5 deficiency |
| RS755972876 | Health Risk | Conflicting classifications of pathogenicity | C3 glomerulonephritis, Inborn genetic diseases, C3 glomerulonephritis |
| RS763857612 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS77159278 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS776063846 | Health Risk | Conflicting classifications of pathogenicity | Inborn genetic diseases, Inborn genetic diseases |
| RS777505173 | Health Risk | Conflicting classifications of pathogenicity | CFHR5 deficiency, Inborn genetic diseases, CFHR5 deficiency |
| RS781568341 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS886045751 | Health Risk | Conflicting classifications of pathogenicity | CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II, CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II |
| RS758392186 | Health Risk | Likely pathogenic | C3 glomerulonephritis, C3 glomerulonephritis |